Transcriptional Suppression of Type 1 Angiotensin II Receptor Gene Expression by Peroxisome Proliferator-Activated Receptor-γ in Vascular Smooth Muscle Cells*

Griendling, 1997, Angiotensin II signaling in vascular smooth muscle. New concepts., Hypertension, 29, 366, 10.1161/01.HYP.29.1.366

Berk, 1999, Angiotensin II signal transduction in vascular smooth muscle: pathways activated by specific tyrosine kinases, J Am Soc Nephrol, 10, S62

Paradis, 2000, Overexpression of angiotensin II type I receptor in cardiomyocytes induces cardiac hypertrophy and remodeling., Proc Natl Acad Sci USA, 97, 931, 10.1073/pnas.97.2.931

Nataraj, 1999, Angiotensin II regulates cellular immune responses through a calcineurin-dependent pathway., J Clin Invest, 104, 1693, 10.1172/JCI7451

Murphy, 1992, Molecular biology of vascular type-1 angiotensin II receptor., Am J Hypertens, 5, 236, 10.1093/ajh/5.12.236S

Timmermans, 1999, Angiotensin II receptor antagonists: an emerging new class of cardiovascular therapeutics, Hypertens Res, 22, 147, 10.1291/hypres.22.147

Takeuchi, 1993, Molecular structure and transcriptional function of the rat vascular AT1a angiotensin receptor gene., Circ Res, 73, 612, 10.1161/01.RES.73.4.612

Ikeda, 1999, Transcriptional suppression of rat angiotensin AT1a receptor gene expression by interferon-gamma in vascular smooth muscle cells., Biochem Biophys Res Commun, 262, 494, 10.1006/bbrc.1999.1226

Forman, 1995, 15-Deoxy-Δ 12, 14-prostaglandin J2 is a ligand for the adipocyte determination factor PPAR γ., Cell, 83, 803, 10.1016/0092-8674(95)90193-0

Lehmann, 1995, An antidiabetic thiazolidinedione is a high affinity ligand for peroxisome proliferator-activated receptor γ (PPAR γ)., J Biol Chem, 270, 12953, 10.1074/jbc.270.22.12953

Juge-Aubry, 1997, DNA binding properties of peroxisome proliferator-activated receptor subtypes on various natural peroxisome proliferator response elements. Importance of the 5′-flanking region., J Biol Chem, 272, 25252, 10.1074/jbc.272.40.25252

Spiegelman, 1998, PPAR-γ: adipogenic regulator and thiazolidinedione receptor., Diabetes, 47, 507, 10.2337/diabetes.47.4.507

Ricote, 1998, The peroxisome proliferator-activated receptor-γ is a negative regulator of macrophage activation., Nature, 391, 79, 10.1038/34178

Jiang, 1998, PPAR-γ agonists inhibit production of monocyte inflammatory cytokines., Nature, 391, 82, 10.1038/34184

Ross, 1999, Atherosclerosis—an inflammatory disease., N Engl J Med, 340, 115, 10.1056/NEJM199901143400207

Marx, 1998, Peroxisome proliferator-activated receptor γ activators inhibit gene expression and migration in human vascular smooth muscle cells., Circ Res, 83, 1097, 10.1161/01.RES.83.11.1097

Iijima, 1998, Expression of peroxisome proliferator-activated receptor γ (PPARγ) in rat aortic smooth muscle cells., Biochem Biophys Res Commun, 247, 353, 10.1006/bbrc.1998.8794

Kliewer, 1994, Differential expression and activation of a family of murine peroxisome proliferator-activated receptors., Proc Natl Acad Sci USA, 91, 7355, 10.1073/pnas.91.15.7355

Mangelsdorf, 1992, Characterization of three RXR genes that mediate the action of 9-cis retinoic acid., Genes Dev, 6, 329, 10.1101/gad.6.3.329

Kobayashi, 1996, Cooperative interaction between AhR.Arnt and Sp1 for the drug-inducible expression of CYP1A1 gene., J Biol Chem, 271, 12310, 10.1074/jbc.271.21.12310

Sugawara, 1997, Retinoid X receptors in the kidney: their protein expression and functional significance., Endocrinology, 138, 3175, 10.1210/endo.138.8.5351

Murphy, 1991, Isolation of a cDNA encoding the vascular type-1 angiotensin II receptor., Nature, 351, 233, 10.1038/351233a0

Park, 1997, PPAR-γ gene expression is elevated in skeletal muscle of obese and type II diabetic subjects., Diabetes, 46, 1230, 10.2337/diab.46.7.1230

Takahashi, 1998, Structure and transcriptional function of the 5′-flanking region of rat thromboxane receptor gene., Biochem Biophys Res Commun, 244, 489, 10.1006/bbrc.1998.8283

Wang, 1998, Immunolocalization of subtype 2 angiotensin II (AT2) receptor protein in rat heart., Hypertension, 32, 78, 10.1161/01.HYP.32.1.78

Sugawara, 1995, Isoform-specific retinoid-X receptor (RXR) antibodies detect differential expression of RXR proteins in the pituitary gland., Endocrinology, 136, 1766, 10.1210/endo.136.4.7895689

Dynan, 1983, The promoter-specific transcription factor Sp1 binds to upstream sequences in the SV40 early promoter., Cell, 35, 79, 10.1016/0092-8674(83)90210-6

Graf, 1997, Troglitazone inhibits angiotensin II-induced DNA synthesis and migration in vascular smooth muscle cells., FEBS Lett, 400, 119, 10.1016/S0014-5793(96)01371-3

Goetze, 1999, Troglitazone inhibits angiotensin II-induced extracellular signal-regulated kinase 1/2 nuclear translocation and activation in vascular smooth muscle cells., FEBS Lett, 452, 277, 10.1016/S0014-5793(99)00624-9

Scheinman, 1995, Characterization of mechanisms involved in transrepression of NF-κB by activated glucocorticoid receptors., Mol Cell Biol, 15, 943, 10.1128/MCB.15.2.943

Ikeda, 2000, Suppression of rat thromboxane synthase gene transcription by peroxiosme proliferator-activated receptor in macrophages via an interaction with NF-E2 related factor 2., J Biol Chem, 275, 33142, 10.1074/jbc.M002319200

Sugawara, 1998, Negative regulation of rat thromboxane receptor gene by 15-deoxy-Δ12, 14-PGJ2 and troglitazone by activating PPAR-γ in vascular smooth muscle cells., J Am Soc Nephrol, 9, 358

Satoh, 1999, Thiazolidinediones suppress endothelin-1 secretion from bovine vascular endothelial cells: a new possible role of PPARγ on vascular endothelial function., Biochem Biophys Res Commun, 254, 757, 10.1006/bbrc.1998.0126

Kato, 1999, Thiazolidinediones down-regulate plasminogen activator inhibitor type 1 expression in human endothelial cells: a possible role of PPARγ in endothelial function., Biochem Biophys Res Commun, 258, 431, 10.1006/bbrc.1999.0648

Law, 1996, Troglitazone inhibits vascular smooth muscle cell growth and intimal hyperplasia., J Clin Invest, 98, 1897, 10.1172/JCI118991

Tontonoz, 1998, PPARγ promotes monocyte/macrophage differentiation and uptake of oxidized LDL., Cell, 93, 241, 10.1016/S0092-8674(00)81575-5

Nagy, 1998, Oxidized LDL regulates macrophage gene expression through ligand activation of PPARγ., Cell, 93, 229, 10.1016/S0092-8674(00)81574-3

Shinohara, 1998, Troglitazone suppresses intimal formation following balloon injury in insulin-resistant Zucker fatty rats., Atherosclerosis, 136, 275, 10.1016/S0021-9150(97)00220-7

Ogihara, 1995, Enhancement of insulin sensitivity by troglitazone lowers blood pressure in diabetic hypertensives., Am J Hypertens, 8, 316, 10.1016/0895-7061(95)96214-5

Imano, 1988, Effect of troglitazone on microalbuminuria in patients with incipient diabetic nephropathy., Diabetes Care, 21, 2135, 10.2337/diacare.21.12.2135

Ghazzi, 1997, Cardiac and glycemic benefits of troglitazone treatment in NIDDM. The Troglitazone Study Group., Diabetes, 46, 433, 10.2337/diab.46.3.433